IL1B and Parkinson disease: In addition, in PD mice triggered by LPS, isoliquiritigenin decreases the expression of TNF-α, IL-1β, and IL-6 via the JNK/NFκB/AKT pathway, reducing neuroinflammation and safeguarding dopaminergic neurons.[142]